Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Radiation Necrosis

Radiation Necrosis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Radiation Necrosis

2 trials tracked for Radiation Necrosis.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 1 Other / NA 1
  1. Phase 2 Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI) Completed
  2. N/A Laser Ablation After Stereotactic Radiosurgery Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Symptomatic radiation necrosis occurs in 5.7% of intracranial brachytherapy patients
Oncology Meta-analysis
Symptomatic radiation necrosis occurs in 5.7% of intracranial brachytherapy patients Brachytherapy for brain tumors: 5.7% risk of radiation necrosis
This meta-analysis of 3666 patients undergoing intracranial brachytherapy for glioma, brain metastases, or meningioma found a pooled inciden…
About 1 in 18 patients who get internal radiation for brain tumors develop symptomatic radiation necrosis, a new analysis finds.
Jun 18, 2026